190 related articles for article (PubMed ID: 7524233)
1. The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer.
Crawford ED; Kozlowski JM; Debruyne FM; Fair WR; Logothetis CJ; Balmer C; Robinson RG; Porter AT; Kirk D
Urology; 1994 Oct; 44(4):481-5. PubMed ID: 7524233
[No Abstract] [Full Text] [Related]
2. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
Sun SS; Tsai SC; Hsieh JF; Lee JK; Kao CH
Clin Nucl Med; 2001 Feb; 26(2):167-9. PubMed ID: 11201488
[No Abstract] [Full Text] [Related]
4. Treating symptomatic osseous metastases from prostate cancer.
Soffen EM; Greenberg AS; Baumann JC
N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
[No Abstract] [Full Text] [Related]
5. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
6. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
[TBL] [Abstract][Full Text] [Related]
7. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
8. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
[TBL] [Abstract][Full Text] [Related]
9. [Strontium-89: a desirable therapeutic for bone metastases of prostate cancer].
Ma YB; Yan WL; Dai JC; Xu F; Yuan Q; Shi HH
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):819-22. PubMed ID: 18998467
[TBL] [Abstract][Full Text] [Related]
10. Pain palliation and nuclear medicine.
McEwan AJ
Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
[No Abstract] [Full Text] [Related]
11. The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases.
Ron IG; Stav O; Vishne T; Evan-Sapir E; Soyfer V; Agai R; Cherny N; Kovner F
Am J Clin Oncol; 2004 Oct; 27(5):500-4. PubMed ID: 15596920
[TBL] [Abstract][Full Text] [Related]
12. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases.
Kasalický J; Krajská V
Eur J Nucl Med; 1998 Oct; 25(10):1362-7. PubMed ID: 9818274
[TBL] [Abstract][Full Text] [Related]
13. Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.
Robinson RG; Blake GM; Preston DF; McEwan AJ; Spicer JA; Martin NL; Wegst AV; Ackery DM
Radiographics; 1989 Mar; 9(2):271-81. PubMed ID: 2467331
[TBL] [Abstract][Full Text] [Related]
14. Procedure guideline for bone pain treatment: 1.0. Society of Nuclear Medicine.
Silberstein E; Taylor A
J Nucl Med; 1996 May; 37(5):881-4. PubMed ID: 8965169
[No Abstract] [Full Text] [Related]
15. [Effectiveness of repeated systematic radiotherapy for generalized prostate cancer].
Kiselev EN; Korytova LI; Karelin MI
Vopr Onkol; 2005; 51(6):689-91. PubMed ID: 17037036
[TBL] [Abstract][Full Text] [Related]
16. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
Giammarile F; Mognetti T; Resche I
Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
[TBL] [Abstract][Full Text] [Related]
17. [89Sr Therapy for pain relief in patients with bone metastases].
Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
[TBL] [Abstract][Full Text] [Related]
18. Palliative hemibody irradiation in hormonally refractory metastatic prostate cancer.
Nseyo UO; Fontanesi J; Naftulin BN
Urology; 1989 Aug; 34(2):76-9. PubMed ID: 2474883
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation in a patient treated with strontium-89 for metastatic carcinoma of the prostate.
Paszkowski AL; Hewitt DJ; Taylor A
Clin Nucl Med; 1999 Nov; 24(11):852-4. PubMed ID: 10551466
[TBL] [Abstract][Full Text] [Related]
20. Targeted radionuclide therapy for bone metastases.
Lewington VJ
Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
